H. Scheerens et al., THE INVOLVEMENT OF SENSORY NEUROPEPTIDES IN TOLUENE DIISOCYANATE-INDUCED TRACHEAL HYPERREACTIVITY IN THE MOUSE AIRWAYS, British Journal of Pharmacology, 119(8), 1996, pp. 1665-1671
1 Recently, we developed a murine model to investigate toluene diisocy
anate (TDI)-induced occupational asthma. After skin-sensitization and
intranasal challenge with TDI (1%) mice exhibited tracheal hyperreacti
vity 24 h after the challenge. 2 The aim of the present study was to i
nvestigate the possible role for sensory neuropeptides in the developm
ent of this tracheal hyperreactivity. 3 First, we demonstrated that di
rect application of TDI in vitro induced the release of tachykinins fr
om the sensory nerves in the mouse isolated trachea. Second, capsaicin
pretreatment, resulting in the depletion of sensory neuropeptides, co
mpletely abolished the TDI-induced tracheal hyperreactivity 24 h after
the challenge. Third, the selective neurokinin(1) (NK1)-receptor anta
gonist RP 67580 (0.2 mu mol kg(-1)) also inhibited tracheal hyperreact
ivity when it was administered before the challenge. However, administ
ration of RP 67580 during the sensitization phase did not result in a
suppression of the TDI-induced tracheal hyperreactivity 24 after the c
hallenge. 4 When TDI-sensitized mice were topically challenged with TD
I a marked ear swelling response was observed. The cutaneous response
after TDI application was not affected by capsaicin pretreatment or RP
67580 administration. 5 These results clearly show that sensory neuro
peptides, particularly tachykinins, are essential for the development
of TDI-induced tracheal hyperreactivity during the effector phase. The
differences between the airways and skin with respect to the sensory
neuropeptides is intriguing and could suggest a local action for the t
achykinins in the airways.